Apellis Pharmaceuticals, Inc. (APLS)
23.79
+0.16
(+0.68%)
USD |
NASDAQ |
Dec 08, 16:00
23.80
+0.01
(+0.04%)
Pre-Market: 09:18
Apellis Pharmaceuticals Shareholders Equity (Quarterly): 401.17M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.21B |
| Amicus Therapeutics, Inc. | 230.42M |
| Fortress Biotech, Inc. | 55.86M |
| Ultragenyx Pharmaceutical, Inc. | 9.159M |
| Fulcrum Therapeutics, Inc. | 198.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.059B |
| Total Liabilities (Quarterly) | 657.56M |
| Debt to Equity Ratio | 1.185 |
| Current Ratio | 3.544 |
| Net Debt Paydown Yield | -0.01% |